Skip to main content

Advertisement

Log in

The value of preoperative screening colonoscopies in patients with biliary tract cancer

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The purpose of this study was to evaluate the value of preoperative screening colonoscopies in patients with biliary tract cancer.

Methods

A total of 544 patients with biliary tract cancer who underwent preoperative screening colonoscopies between January 2005 and December 2012 were retrospectively analyzed.

Results

Synchronous colorectal neoplasia was detected in 199 patients (36.7 %), with adenocarcinomas detected in 21 (3.9 %) patients, carcinoids in two (0.4 %) patients, and adenomas in 176 (32.4 %) patients. Of those with adenomas, 32 patients were diagnosed with advanced adenomas, defined as adenomas with a maximum diameter of >1 cm, villous histology, or high-grade dysplasia because these characteristics implied the risk of malignant transformation. Fifty-five (10.1 %) of the patients with colorectal neoplasia required resection (11 surgical and 44 endoscopic resections). There were no major adverse events related to the resection. Univariate and multivariate analyses revealed that smoking status [ex-smoker + current smoker vs. non-smoker: odds ratio (OR) 2.32; 95 % confidence interval (CI) 1.30−4.21] and advanced age (≥70 vs. ≤69 years: OR 2.22; 95 % CI 1.24−3.91) were independent risk factors of having a colorectal neoplasia that required resection.

Conclusions

In patients with biliary tract cancer, preoperative screening colonoscopy was feasible and provided valuable clinical information. Synchronous colorectal neoplasia was detected in a substantial number of patients. Preoperative screening colonoscopies should be considered especially in high-risk patients such as smokers and elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129–40.

    Article  PubMed  Google Scholar 

  2. Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.

    Article  PubMed  Google Scholar 

  3. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706–14.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg. 2013;257:121–7.

    Article  PubMed  Google Scholar 

  6. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–7.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115–23.

    Article  PubMed  Google Scholar 

  8. Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.

    Article  PubMed  Google Scholar 

  9. Okusaka T, Nakachi K, Fukutomi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010;103:469–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.

    Article  PubMed  Google Scholar 

  11. Riall TS, Stager VM, Nealon WH, et al. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg. 2007;204:803–13, Discussion 13−4.

    Article  PubMed  Google Scholar 

  12. Ueno M, Muto T, Oya M, et al. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol. 2003;8:162–7.

    Article  PubMed  Google Scholar 

  13. Saito S, Hosoya Y, Togashi K, et al. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surg Today. 2008;38:20–5.

    Article  PubMed  Google Scholar 

  14. Eom BW, Lee HJ, Yoo MW, et al. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol. 2008;98:106–10.

    Article  PubMed  Google Scholar 

  15. Lee JH, Bae JS, Ryu KW, et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588–92.

    PubMed Central  PubMed  Google Scholar 

  16. Yoo HM, Gweon TG, Seo HS, et al. Role of preoperative colonoscopy in patients with gastric cancer: a case control study of the prevalence of coexisting colorectal neoplasms. Ann Surg Oncol. 2013;20:1614–22.

    Article  PubMed  Google Scholar 

  17. Park DI, Park SH, Yoo TW, et al. The prevalence of colorectal neoplasia in patients with gastric cancer: a Korean Association for the Study of Intestinal Disease (KASID) Study. J Clin Gastroenterol. 2010;44:102–5.

    Article  PubMed  Google Scholar 

  18. Kim HO, Hwang SI, Yoo CH, et al. Preoperative colonoscopy for patients with gastric adenocarcinoma. J Gastroenterol Hepatol. 2009;24:1740–4.

    Article  PubMed  Google Scholar 

  19. Yoon SN, Oh ST, Lim SB, et al. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg. 2010;34:2168–76.

    Article  PubMed  Google Scholar 

  20. World Health Organization. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000.

    Google Scholar 

  21. Schulmann K, Reiser M, Schmiegel W. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol. 2002;16:91–114.

    Article  PubMed  Google Scholar 

  22. Kim SY, Jung SW, Hyun JJ, et al. Is colonoscopic screening necessary for patients with gastric adenoma or cancer? Dig Dis Sci. 2013;58:3263–9.

    Article  PubMed  Google Scholar 

  23. Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.

    Article  PubMed  Google Scholar 

  24. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum. 2000;43:S78–84.

    Article  CAS  PubMed  Google Scholar 

  25. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–8.

    Article  PubMed  Google Scholar 

  26. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Yoshinaga M, Motomura S, Takeda H, et al. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia. Am J Gastroenterol. 1995;90:1076–9.

    CAS  PubMed  Google Scholar 

  28. Lieberman D. Colorectal cancer screening: practice guidelines. Dig Dis. 2012;30[Suppl 2]:34–8.

    Article  PubMed  Google Scholar 

  29. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359:1207–17.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet. 2013;381:1194–202.

    Article  PubMed  Google Scholar 

  31. American Institute for Cancer Research/World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.

  32. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.

    Article  CAS  PubMed  Google Scholar 

  33. Lim SB, Jeong SY, Choi HS, et al. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea. Int J Colorectal Dis. 2008;23:61–5.

    Article  CAS  PubMed  Google Scholar 

  34. Lee WS, Lee JN, Choi S, et al. Multiple primary malignancies involving colorectal cancer—clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg. 2010;395:359–64.

    Article  PubMed  Google Scholar 

  35. World Health Organization. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC Press; 2010.

    Google Scholar 

  36. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Castro FA, Koshiol J, Hsing AW, et al. Biliary tract cancer incidence in the United States—demographic and temporal variations by anatomic site. Int J Cancer. 2013;133:1664–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Doucas H, Garcea G, Neal CP, et al. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005;41:365–79.

    Article  CAS  PubMed  Google Scholar 

  39. Itatsu K, Zen Y, Ohira S, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007;27:1174–84.

    Article  PubMed  Google Scholar 

  40. Burmer GC, Loeb LA. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA. 1989;86:2403–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001;121:542–7.

    Article  CAS  PubMed  Google Scholar 

  42. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.

    Article  PubMed  Google Scholar 

  43. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1–8.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keita Itatsu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Itatsu, K., Yokoyama, Y., Ebata, T. et al. The value of preoperative screening colonoscopies in patients with biliary tract cancer. J Gastroenterol 51, 138–143 (2016). https://doi.org/10.1007/s00535-015-1092-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-015-1092-x

Keywords

Navigation